We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Abbott Laboratories has "the best stent," RBC Capital Markets analysts said after data released at the American College of Cardiology's 56th Annual Scientific Session indicated Abbott's Xience stent is superior to Boston Scientific's Taxus stent.
AdvaMed supports a recently announced free trade agreement (FTA) between the U.S. and the Republic of Korea, AdvaMed President and CEO Stephen Ubl said.
The FDA told RyMed Technologies during a meeting that the firm's initial response to a Form 483 regarding alleged current good manufacturing practice violations satisfied the agency's concerns, according to the firm.
Medical device companies "overwhelmingly" accept AdvaMed's Code of Ethics on Interactions with Health Care Professionals, but they face "significant challenges" in implementing the code, according to a white paper released March 29.
After pressure from Congress, federal investigators will reopen 103 cases of potential conflicts of interest among NIH employees, according to HHS Inspector General Daniel Levinson.
After a special committee investigated Biomet's stock option grants from 1996 to the present, the company announced that the committee found "Biomet's public filings with regard to stock options were inaccurate."
The military spends billions of dollars annually in partnerships with medical devicemakers, particularly in the areas of R&D and acquisition, David Hood, senior adviser for the Army's Medical Research and Material Command (MRMC), said.